Jun Wu

Lycium barbarum Glycopeptide prevents the development and progression of acute colitis by regulating the composition and diversity of the gut microbiota in mice

K. So, Kaili Nie, Yinghui Zheng, 2022, Frontiers in Cellular and Infection Microbiology.

An Antioxidant Enzyme Therapeutic for Sepsis

Yunfeng Lu, Ran Yan, Chaoyong Liu, 2021, Frontiers in Bioengineering and Biotechnology.

An Antioxidant Enzyme Therapeutic for COVID‐19

F. Wang, Kaili Nie, Yunfeng Lu, 2020, Advanced materials.

An Antioxidant Enzyme Therapeutic for COVID-19

F. Wang, Kaili Nie, Yunfeng Lu, 2020, bioRxiv.

An inflammation-targeted nanoparticle with bacteria forced release of polymyxin B for pneumonia therapy.

Fang Wang, Q. Zhan, Peisen Zhang, 2022, Nanoscale.

Mucus-permeable polymyxin B-hyaluronic acid/ poly (lactic-co-glycolic acid) nanoparticle platform for the nebulized treatment of lung infections.

Fang Wang, L. Deng, Q. Zhan, 2022, Journal of colloid and interface science.

Corrigendum: Lycium barbarum Glycopeptide prevents the development and progression of acute colitis by regulating the composition and diversity of the gut microbiota in mice

K. So, Kaili Nie, Yinghui Zheng, 2022, Frontiers in Cellular and Infection Microbiology.